Home sleep study for patients with myasthenia gravis

J. H. Yeh, C. M. Lin, H. C. Chiu, C. H. Bai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41%) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.

Original languageEnglish
Pages (from-to)191-195
Number of pages5
JournalActa Neurologica Scandinavica
Volume132
Issue number3
DOIs
Publication statusPublished - 2015

Fingerprint

Myasthenia Gravis
Sleep Apnea Syndromes
Sleep
Azathioprine
Cholinergic Receptors
Antibodies
Muscle Weakness
Health

Keywords

  • acetylcholine receptor antibody
  • body mass index
  • myasthenia gravis
  • peripheral arterial tone
  • polysomnography
  • sleep-disordered breathing

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Home sleep study for patients with myasthenia gravis. / Yeh, J. H.; Lin, C. M.; Chiu, H. C.; Bai, C. H.

In: Acta Neurologica Scandinavica, Vol. 132, No. 3, 2015, p. 191-195.

Research output: Contribution to journalArticle

Yeh, J. H. ; Lin, C. M. ; Chiu, H. C. ; Bai, C. H. / Home sleep study for patients with myasthenia gravis. In: Acta Neurologica Scandinavica. 2015 ; Vol. 132, No. 3. pp. 191-195.
@article{4395f8130daf42f78858d01fc6825ebd,
title = "Home sleep study for patients with myasthenia gravis",
abstract = "Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41{\%}) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.",
keywords = "acetylcholine receptor antibody, body mass index, myasthenia gravis, peripheral arterial tone, polysomnography, sleep-disordered breathing",
author = "Yeh, {J. H.} and Lin, {C. M.} and Chiu, {H. C.} and Bai, {C. H.}",
year = "2015",
doi = "10.1111/ane.12382",
language = "English",
volume = "132",
pages = "191--195",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Home sleep study for patients with myasthenia gravis

AU - Yeh, J. H.

AU - Lin, C. M.

AU - Chiu, H. C.

AU - Bai, C. H.

PY - 2015

Y1 - 2015

N2 - Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41%) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.

AB - Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41%) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.

KW - acetylcholine receptor antibody

KW - body mass index

KW - myasthenia gravis

KW - peripheral arterial tone

KW - polysomnography

KW - sleep-disordered breathing

UR - http://www.scopus.com/inward/record.url?scp=85006476276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006476276&partnerID=8YFLogxK

U2 - 10.1111/ane.12382

DO - 10.1111/ane.12382

M3 - Article

AN - SCOPUS:85006476276

VL - 132

SP - 191

EP - 195

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 3

ER -